An Open-label Long-term Safety Study of Buntanetap in Participants With AD
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07757204. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label Clinical Trial Investigating the Long-term Safety of Buntanetap in Treating Participants With Alzheimer's Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will examine the long-term safety of buntanetap in participants with AD who have participated in a prior study of buntanetap in AD.
Study identification
- NCT ID
- NCT07757204
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 400 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 55 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 21, 2026 (Estimated)
- Primary completion
- Feb 21, 2030 (Estimated)
- Completion
- May 2030 (Estimated)
- Last update posted
- Nov 12, 2026
2026 – 2030
United States locations
- U.S. sites
- 14
- U.S. states
- 7
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cenexel Rocky Mountain Clinical Research | Englewood | Colorado | 80113 | — |
| K2 Medical Research Daytona | Daytona Beach | Florida | 32114 | — |
| K2 Medical Research | Maitland | Florida | 32751 | — |
| Merritt Island Medical Research, LLC | Merritt Island | Florida | 32952 | — |
| Conquest Research | Orlando | Florida | 32832 | — |
| Conquest Research, LLC | Winter Park | Florida | 32789 | — |
| Accel Neurosciences | Decatur | Georgia | 30030 | — |
| Center for Advanced Research & Education | Gainesville | Georgia | 30501 | — |
| Cenexel Advanced Medical Research of New Jersey (AMRI) | Toms River | New Jersey | 08755 | — |
| Advanced Clinical Institute | West Long Branch | New Jersey | 07764 | — |
| AMC Research/Flourish Research | Matthews | North Carolina | 28105 | — |
| Senior Adults Specialty Research | Austin | Texas | 78757 | — |
| Central Texas Neurology Associates | Round Rock | Texas | 78681 | — |
| Sana Research | Arlington | Virginia | 22205 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07757204, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 12, 2026 · Synced Nov 15, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.